Moreover, there are a few case reports indicating a correlation between TNF-α inhibitors and oral lichen planus [25] and between Infliximab (another TNF-α inhibitor) and oral ulcerations since it has been demonstrated to be immunogenic and leads to antibodies to infliximab related to painful oral ulcerations [26]. The gene discussed is TNF; the disease is ulcer disease.